- ￥2000 - 8000
- 湖北省武汉市
- Human PTPRC重组蛋白表达
- 2025年10月27日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 服务名称：
大肠杆菌系统重组蛋白表达
- 提供商：
普健生物（武汉）科技有限公司
Uniprot号：P08575
基因名：PTPRC
蛋白名：Receptor-type tyrosine-protein phosphatase C (EC 3.1.3.48) (Leukocyte common antigen) (L-CA) (T200) (CD antigen CD45)
蛋白别名：
Receptor-type tyrosine-protein phosphatase C, 3.1.3.48, Leukocyte common antigen, L-CA, T200, CD45, EC:3.1.3.48
服务内容：
| 服务项目 | 客户提供 | 服务内容 | 服务周期 | 交付内容 |
|---|---|---|---|---|
| 大肠杆菌系统 蛋白表达 | 基因序列 | 方案沟通 | 1天 | 方案报告 |
| 密码子优化和基因合成 | 5天 | 基因合成报告 | ||
| 表达纯化测试 | 3天 | 表达纯化测试报告 | ||
| 1L表达及纯化 | 3天 | 蛋白样品(3-5mg)及报告 | ||
| 放大发酵及纯化 | 7天 | 纯化的蛋白及报告 |
案例展示：
PTPRC相关研究文献：
1. Protein tyrosine phosphatase receptor type C (PTPRC or CD45). [34039664]
2. PTPRC functions as a prognosis biomarker in the tumor microenvironment of cutaneous melanoma. [37996489]
3. PTPRC promoted CD8+ T cell mediated tumor immunity and drug sensitivity in breast cancer: based on pan-cancer analysis and artificial intelligence modeling of immunogenic cell death-based drug sensitivity stratification. [37388747]
4. PTPRC Inhibits Ferroptosis of Osteosarcoma Cells via Blocking TFEB/FTH1 Signaling. [37851191]
5. PTPRC Overexpression Predicts Poor Prognosis and Correlates with Immune Cell Infiltration in Pediatric Acute Myeloid Leukemia. [35975530]
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验- Accelerating wound closure with metrnl in normal and diabetic mouse skin
- A sensitive and high-throughput flow cytometry-based assay for measuring antibody neutralization of human adenovirus type 3
- Development of an immunoassay based on a specific antibody for the detection of diphenyl ether herbicide fomesafen
- Natural Shrimp (Litopenaeus vannamei) tropomyosin shows higher allergic properties than recombinant ones as compared through SWATH-MS-based proteomics and immunological response
- RNA m6A methylation suppresses insect juvenile hormone degradation to minimize fitness costs in response to a pathogenic attack
技术资料暂无技术资料 索取技术资料
